Macrobid vs. Fosfomycin
See how Macrobid and Fosfomycin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Macrobid is taken twice daily for a full week, while Fosfomycin is given as a single one-time dose.
Macrobid is contraindicated in patients with reduced kidney function, while Fosfomycin carries no such restriction.
Macrobid also covers S. saprophyticus infections, while Fosfomycin also covers E. faecalis.
Macrobid vs. Fosfomycin Drug Summary
Macrobid
Macrobid is a nitrofuran antibiotic used to treat uncomplicated urinary tract infections caused by susceptible E. coli or S. saprophyticus. It comes as an oral capsule taken twice a day for seven days to clear the infection.
Fosfomycin
Fosfomycin is a phosphonic acid derivative antibiotic used to treat uncomplicated urinary tract infections in women caused by susceptible E. coli or E. faecalis. It comes as oral granules mixed with water and taken as a single one-time dose.
Macrobid vs. Fosfomycin Side Effects
Macrobid
Fosfomycin
Macrobid vs. Fosfomycin Dosage
Macrobid
Fosfomycin
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 3 g single dose | At the start |
| Maximum dose | 3 g single dose | Same as starting |
| Dose changes | None | Fixed dose |
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Fosfomycin
| STAGE | DOSE | WHEN |
| Starting dose | 3 g single dose | At the start |
| Maximum dose | 3 g single dose | Same as starting |
| Dose changes | None | Fixed dose |
Macrobid vs. Fosfomycin Indications
Macrobid
Macrobid is FDA-approved for acute uncomplicated cystitis caused by susceptible E. coli or S. saprophyticus. Doctors also prescribe it off-label at a lower daily dose to prevent recurrent UTIs. It is not effective for kidney infections or infections that have spread beyond the bladder.
Acute uncomplicated cystitis (E. coli or S. saprophyticus)
Off-label: long-term low-dose prophylaxis for recurrent UTIs
Not approved for pyelonephritis or perinephric abscess
Not approved for children under 12 or infants under 1 month
Fosfomycin
Fosfomycin is FDA-approved for acute uncomplicated cystitis in women caused by susceptible E. coli or E. faecalis. Doctors also use it off-label in multi-dose regimens for complicated UTIs and chronic bacterial prostatitis. It is not approved for use in men or for pyelonephritis.
Acute uncomplicated cystitis in women (E. coli or E. faecalis)
Off-label: multi-dose regimens for complicated UTI or pyelonephritis
Off-label: chronic bacterial prostatitis
Not approved for use in men or children 12 and under
Macrobid vs. Fosfomycin Pros and Cons
Macrobid
Macrobid has a long track record, and E. coli resistance to it remains low despite decades of use. It requires a full week of twice-daily dosing and carries several rare but serious warnings, including lung and liver toxicity with prolonged use.
Pros
Low E. coli resistance rates despite decades of use
Also covers S. saprophyticus infections
Concentrates heavily in urine for targeted action
Available as low-cost generic
Cons
Requires twice-daily dosing for a full 7-day course
Contraindicated with reduced kidney function (CrCl under 60)
Carries warnings for pulmonary and liver toxicity
Not for use in infants or in late pregnancy
Fosfomycin
Fosfomycin's single-dose regimen makes it appealing for patients who struggle with multi-day antibiotic courses. It carries no boxed warnings, but its one-time dosing limits its use to straightforward, uncomplicated infections.
Pros
Single one-time dose instead of a multi-day course
No boxed warnings on the label
Also covers E. faecalis infections
Safe option regardless of kidney function status
Cons
Only approved for use in women, not men
Higher rates of diarrhea and vaginitis than Macrobid
Repeated dosing does not improve efficacy, limiting flexibility
Not approved for pyelonephritis or complicated UTI
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.